A complement fixation procedure for the serological diagnos of histoplasmosis in a human patient was attempted first in 1941 by Van Pernis, Benson, and Hollinger. The results were negative with an antigen which consisted of the undiluted filtrate (histoplasmin) from a glucose broth medium inoculated with Hidtoplasma capsulatum. Since that time other types of antigens have been developed by various investigators. Salvin (1947) found that yeast phase cells of H. capsulatum reacted with sera from rabbits infected with the same fungus, but that histoplasmin failed to give reactions. This reactivity of yeast phase antigen with rabbit sera was confirmed by Saslaw and Campbell (1948a) . Tenenberg and Howell (1948) , however, found that histoplasmin was a satisfactory antigen for detecting complement-fixing antibodies in guinea pigs experimentaRly inoculated with H. capsulatuum. Furcolow, Bunnell, and Tennenberg (1948) , using Howell's antigen, detected 14 positive complement fixation reactors among 300 patients suspected of having histoplasmosis. On the basis of comparative tests with whole yeast phase cells, ground yeast phase cells, and histoplasmin, on sera from two proven hulman cases of histoplasmosis and hyperimmunized rabbits, Grayston (1952) (Schubert et al., 1953) and its readiness of conversion to the yeast phase.
Histoplamin. Histoplasmin was obtained by growing strain 105 for 6 months on the modified (Tuberculin) medium of the Bureau of Animal Industry (Smith et al., 1948 Other factors which may have contributed to differences in serological results include the tendency to employ hyperimmune rabbit sera as the agents to titrate antigenic potency and the failure to distinguish between antibody patterns developed in hyperimmunization and those resulting from infection. In addition, it has been known for many years that antibodies from various species of animals react differently in the complement fixation test which employs guinea pig complement, depending upon whether or not protein or carbohydrate antigens from bacterial sources are used as antigens. Martin (1953) showed that anti-Blastomyces hyperimmune rabbit serum fixes guinea pig complement with a nonprotein surface material from Blastomyces dermatitidis, whereas fixation with the same antigen does not occur with sera from infected humans. On the other hand, sera from both hyperimmune rabbits and infected humans fix guinea pig complement with an antigen liberated from the fungus cells by sonic vibration.
The experiments presented in this paper, although preliminary in nature, emphasize some of the points discussed above. The sera from eight hyperimmune rabbits (table 1) The whole yeast phase antigen gave no reaction with these sera at the 1:4 dilution. In direct contrast, the results obtained with serum specimens from 11 culturally positive (table 2) In tests with sera from hyperimmunized rabbits, all three antigens were of relatively equal activity, but with sera from infected rabbits, the whole yeast phase antigen was inferior to the other two antigens.
Histoplasmin was completely unreactive when tested with sera from infected dogs. However, in tests with human sera obtained either from culturally proven cases of histoplasmosis or from presumptive cases, histoplasmin was more reactive than the whole yeast phase or the sonic disintegrated yeast phase antigens used in this study.
It is suggested that H. capsulatum antigens for use in complement fixation tests with human sera should not be preselected on the basis of tests with nonhuman sera.
